61 – 70 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Vasculogenic erectile dysfunction: Newer therapeutic strategies - Discussion
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
-
Mark
Erectile physiological and pathophysiological pathways involved in erectile dysfunction.
(
- Contribution to journal › Article
-
Mark
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Third International Conference on the Management of Erectile Dysfunction: Linking pathophysiology and therapeutic response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Bladder overactivity in mice after 1 week of outlet obstruction. Mainly afferent dysfunction?
(
- Contribution to journal › Article
-
Mark
Expression of nitric oxide synthase immunoreactivity in the human female intramural striated urethral sphincter
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable
(
- Contribution to journal › Article
-
Mark
Morphology phenotype and ultrastructure of fibroblastic cells from normal and neuropathic human detrusor: Absence of myofibroblast characteristics
(
- Contribution to journal › Article